Hyperphosphatemia

Education Can Improve Phosphate Control

Education Can Improve Phosphate Control

By

Patients receiving educational or behavioral interventions aimed at controlling hyperphosphatemia had an average reduction in phosphate of 0.23 mmol/L more than standard care patients.

Switch to an Iron-Based Binder Found to Improve Phosphorus Lowering

Switch to an Iron-Based Binder Found to Improve Phosphorus Lowering

By

Converting hemodialysis patient to sucroferric oxyhydroxide from a previous binder increased the proportion of patients achieving target serum phosphorus levels.

Reducing Serum Phosphorus to Safer Target Range Ups Survival

Reducing Serum Phosphorus to Safer Target Range Ups Survival

By

Survival improved by 12% when serum phosphate levels approached a safer target range.

Residual Kidney Function Predicts Mortality in CKD-MBD

Residual Kidney Function Predicts Mortality in CKD-MBD

By

In a study of hemodialysis patients, mortality risk increased along with phosphorus level, particularly among patients with higher residual renal urea clearance.

Initial Low-Dose Etelcalcetide Feasible for SHPT Patients

Initial Low-Dose Etelcalcetide Feasible for SHPT Patients

By

At 18 months, PTH levels were within target for 67% and 68% of participants who initiated etelcalcetide at 2.5 mg and 5 mg, respectively.

Sucroferric Oxyhydroxide Ups Phosphorus Control in SHPT

Sucroferric Oxyhydroxide Ups Phosphorus Control in SHPT

By

Nearly twice as many patients achieved the target phosphorus range after a year of taking the phosphate binder, regardless of iPTH level.

Eliminating Phosphorus Food Additives Does Not Compromise Nutrition

Eliminating Phosphorus Food Additives Does Not Compromise Nutrition

By

Replacing foods containing phosphorus-based additives with similar foods not containing these additives can control hyperphospatemia without interfering with nutritional status.

ALP Predicts Mortality in Peritoneal Dialysis Patients With CKD-MBD

ALP Predicts Mortality in Peritoneal Dialysis Patients With CKD-MBD

By

Alkaline phosphatase was more strongly linked to mortality compared with other biomarkers of chronic kidney disease-mineral and bone disorder.

Elemental Calcium Intake High With Calcium-Based Binder Use

Elemental Calcium Intake High With Calcium-Based Binder Use

By

In a study, 25.8% and 37.8% of calcium acetate and calcium carbonate users, respectively, exceeded the maximum recommended daily intake.

Iron-Based Phosphate Binder Safely Treats Anemia in CKD Patients

Iron-Based Phosphate Binder Safely Treats Anemia in CKD Patients

By

In a study 52.1% of patients receiving ferric citrate attained a 1.0 g/dL or greater increase in hemoglobin compared with just 19.1% receiving placebo.

Phosphate Enemas Can Cause Hyperphosphatemia

Phosphate Enemas Can Cause Hyperphosphatemia

By

Purgative products introduce 10 times the normal daily amount of phosphorus into the body.

Dialysis Patient Age May Affect Hyperphosphatemia Management

Dialysis Patient Age May Affect Hyperphosphatemia Management

By

Younger patients are less likely to respond to treatment with sucroferric oxyhydroxide or sevelamer.

Prescribed Meds May Up Phosphate Burden in Hemodialysis Patients

Prescribed Meds May Up Phosphate Burden in Hemodialysis Patients

By

Study implicates amlodipine, lisinopril, clonidine, acetaminophen, and omeprazole.

Phosphate Binder Switch Found to Benefit Peritoneal Dialysis Patients

Phosphate Binder Switch Found to Benefit Peritoneal Dialysis Patients

By

The percentage of patients with serum phosphorus levels of 5.5 mg/dL and below more than doubled to 37.8% after 6 months of treatment with sucroferric oxyhydroxide.

Sucroferric Oxyhydroxide Helps More Hyperphosphatemia Pts Reach Target

Sucroferric Oxyhydroxide Helps More Hyperphosphatemia Pts Reach Target

By

Patients also needed fewer phosphate binder pills over time.

ESRD Linked to Diet Soda Consumption

ESRD Linked to Diet Soda Consumption

By

The risk of end-stage renal disease was 83% higher for those who drank more than 7 glasses of diet soft drinks weekly.

Intensive Hemodialysis Effective for Treating Hyperphosphatemia

Intensive Hemodialysis Effective for Treating Hyperphosphatemia

By

It can sharply lower serum phosphorus levels and reduce dependence on phosphate binders.

Cutting Phosphorus Additives Reduces Hyperphosphatemia

Cutting Phosphorus Additives Reduces Hyperphosphatemia

By

In a study, 69.7% of intervention patients attained serum phosphorus levels below 5.5 mg/dL, compared with just 18.5% of control patients.

Dietary Management May Aid Transition to Incremental HD

Dietary Management May Aid Transition to Incremental HD

By

A low protein, low phosphorus diet plays an important role in the nutritional management of patients transitioning to once-weekly incremental hemodialysis.

Hyperphosphatemia Linked With Mortality in Septic AKI

Hyperphosphatemia Linked With Mortality in Septic AKI

By

Hyperphosphatemia was associated with more than double the risk of death from any cause.

Teaching Low Phosphorus Cooking May Improve Hyperphosphatemia

Teaching Low Phosphorus Cooking May Improve Hyperphosphatemia

By

Patients reduced dietary phosphorus without compromising protein intake.

Nutritional Databases Underreport Phosphorus Content

Nutritional Databases Underreport Phosphorus Content

By

The USDA Standard Nutrient Reference Database, for example, listed phosphorus amounts for just 5 of 46 beverages.

Serum Phosphorus Linked With Left Ventricular Remodeling

Serum Phosphorus Linked With Left Ventricular Remodeling

By

For each 1 mmol/L increase in serum phosphorus, the odds of left ventricular hypertrophy more than doubled.

Study: Phosphate Binders Do Not Lower Death Risk

Study: Phosphate Binders Do Not Lower Death Risk

By

Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer.

Uncontrolled Phosphorus Linked to Poor Binder Adherence

Uncontrolled Phosphorus Linked to Poor Binder Adherence

By

In a study, 61% of hemodialysis patients reported accidentally forgetting to take their medication or otherwise skipping doses unintentionally.

Natural Vitamin D Supplement Effective for Nondialysis CKD-MBD

Natural Vitamin D Supplement Effective for Nondialysis CKD-MBD

By

Over 33 months, the 25-hydroxyvitamin D level of ergocalciferol recipients increased significantly from 15.14 to 37.32 ng/mL.

Low-Dose Niacin Helps Lower Phosphorus Levels

Low-Dose Niacin Helps Lower Phosphorus Levels

By

Researchers evaluated the efficacy of 100 mg/day of niacin in hemodialysis patients.

Sucroferric Oxyhydroxide Exhibits a Dose-Dependent Effect

Sucroferric Oxyhydroxide Exhibits a Dose-Dependent Effect

By

The phosphate binder is a useful treatment for hyperphosphatemia with a relatively low pill burden, researchers say.

Study: Minimal Risk of Iron Overload With Sucroferric Oxyhydroxide

Study: Minimal Risk of Iron Overload With Sucroferric Oxyhydroxide

By

Patients may need no more than routine evaluation of iron.

Even High-Normal Phosphorus May Be an ESRD Risk Factor, Study Finds

Even High-Normal Phosphorus May Be an ESRD Risk Factor, Study Finds

By

Phosphorus targets in patients with chronic kidney disease stage 3 to 4 should be below 4.3 mg/dL, researchers report.

Sign Up for Free e-newsletters